Gary Guthart's comments on GLP-1 drugs have concerned some investors, but I feel fine about them.It wasn't that long ago that Intuitive Surgical (ISRG 1.04%) was dealing with pandemic-related issues. The company's procedure volume dropped noticeably with the outbreak, leading to lower-than-expected revenue and earnings.Intuitive did bounce back, much to the joy of investors. However, the medical device specialist is now dealing with a completely different issue harming its financial results. During the comp ...